Process2Clean®: Process Cleaning Detergents
VAI’s Process2Clean®, Process Cleaning Detergents, are designed to remove process residues that could contaminate or adulterate further product manufacturing in the pharmaceutical, biotechnology, medical device, and research & development industries.
VAI’s GMP Process2Clean (P2C) cleaning products are specifically formulated for critical process cleaning applications. Each detergent is engineered to effectively remove numerous product residues found in pharmaceutical, biotechnology, medical device, and research & development industries. Process2Clean detergents successfully remove existent residues present in process manufacturing and reduce them down to acceptable trace residual limits. This critical process assures that product contact surfaces are clean prior to subsequent manufacturing and eliminates the possibility of product contamination or product adulteration.
Process2Clean detergents include an Alkaline Detergent, an Acid Based Detergent, a Hydroxyacetic Acid Cleaner, a General Purpose Cleaning Detergent, a Neutral pH Cleaning Additive, and a Chlorinated Alkaline Cleaning Detergent. This complete line of Process2Clean detergents are capable of removing a wide range of residues from inorganic to organic process soils and can be used in numerous cleaning systems from automated to manual.
Process2Clean detergents are formulated with Water for Injection (WFI) and are highly concentrated which translates into low cost per use. All shipments of Process2Clean are delivered with lot specific documentation and are completely validated with an extensive validation support package available. Process2Clean Detergents are available in 1, 5, 30, 55, and 275 gallon options either sterile or non-sterile.
Contact Details:
Company name: Veltek Associates, Inc.
Website: www.sterile.com
E-mail: moira.omalley@sterile.com
Why is the PDA Pharmaceutical Microbiology Conference the Hottest Ticket in the Industry?
October 10th 2024Get a glimpse of the power and popularity behind the PDA Pharmaceutical Microbiology Conference from two planning committee members, Julia Marre, PhD (Associate Director, Scientific and Regulatory Affairs at Pocket Naloxone Corp) and Dawn Watson (Executive Director, Global Micro Quality and Sterility Assurance at Merck). This candid conversation reveals why this industry event is so influential…and always sold out! The speakers discuss what makes the PDA Pharmaceutical Microbiology Conference so vital to industry professionals, as well as how to become a part of this dynamic professional community.
